EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC 4.0

Sex differences in effectiveness of CGRP receptor antagonism for treatment of acute and persistent headache-like pain in a mouse model of mild traumatic brain injury

Edita Navratilova iD, Caroline M Kopruszinski iD, Janice Oyarzo, Kara R Barber, Trent Anderson, David W Dodick, Todd J Schwedt iD, Frank Porreca iD

Cephalalgia · 2025

DOI: 10.1177/03331024251321087 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Cephalalgia, 2025. Verfasst von Edita Navratilova und 7 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pharmacology, Arizona Health Sciences Center, University of Arizona, Tucson, AZ, USA. Hauptthemen laut MEDLINE: Calcitonin Gene-Related Peptide Receptor Antagonists, Sex Characteristics, Brain Concussion, Post-Traumatic Headache. Die Arbeit wurde bisher 11-mal zitiert (Crossref) und nennt 58 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0). Gefördert von: U.S. Department of Defense.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Traumatic brain injury (TBI) commonly elicits acute (APTH) and/or persistent (PPTH) post-traumatic headache. Calcitonin gene related peptide (CGRP) has been implicated as a contributor to PTH pathophysiology. We explored the possibility of sexual dimorphism in the effects of CGRP receptor (CGRP-R) blockade in a preclinical model of PTH induced by a mild TBI (mTBI) in male or female mice.

Methods

Mice were lightly anesthetized and placed on a tissue paper stage prior to receiving a sham procedure or mTBI resulting from a closed-head weight drop injury. Behavioral responses to periorbital and hindpaw tactile (von Frey filaments) or thermal (hot plate) stimuli over the first 14 days post-mTBI were evaluated as measures of APTH. The PPTH phase was studied following the resolution of mTBI-induced APTH at days 14 and 28. PPTH was precipitated by exposure to bright lights (i.e., bright light stress, BLS). Olcegepant was delivered subcutaneously either repeatedly beginning 2 h after mTBI to produce a sustained block of CGRP-R signaling across the APTH phase, or as a single administration on days 14 or 28 post-mTBI to evaluate possible effects during the PPTH phase. Results mTBI, but not sham-procedure, produced periorbital and hindpaw tactile allodynia, as well as thermal hypersensitivity in mice of both sexes. APTH-related hypersensitivity was transient and resolved by day 14 post-injury. No sex differences were observed in the magnitude or duration of APTH-related pain behaviors. Sustained CGRP-R blockade was, however, significantly more effective in female than male mice in inhibiting pain behaviors in the APTH phase and in preventing the emergence of BLS-induced PPTH. CGRP-R blockade following the resolution of mTBI-induced APTH pain behaviors, on either day 14 or 28, minimally altered BLS-induced PPTH in either sex.

Conclusions

Sustained CGRP-R blockade starting soon after mTBI significantly inhibited APTH and prevented the expression of PPTH with greater analgesic effects in females compared to males. Delayed CGRP-R blockade beginning after resolution of APTH phase was minimally effective in preventing expression of PPTH in either sex. These data are consistent with previous observations that CGRP induces pain behaviors preferentially in females. Early and continuous CGRP blockade following mTBI may represent a viable treatment option for PTH treatment and the prevention of PTH persistence, especially in females.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Calcitonin Gene-Related Peptide Receptor AntagonistsSex CharacteristicsBrain ConcussionPost-Traumatic HeadacheAzepinesAnimalsMaleMiceFemaleDisease Models, AnimalMice, Inbred C57BLReceptors, Calcitonin Gene-Related PeptidePiperazinesQuinazolines

Stichwörter der Autor:innen

CGRP receptor antagonistcalcitonin gene-related peptideconcussionmild traumatic brain injuryolcegepantpost-traumatic headache

Substanzen

Calcitonin Gene-Related Peptide Receptor AntagonistsolcegepantAzepinesReceptors, Calcitonin Gene-Related PeptidePiperazinesQuinazolines

Autor:innen und Institutionen

  • Department of Pharmacology, Arizona Health Sciences Center, University of Arizona, Tucson, AZ, USA.
  • Department of Neurology, Mayo Clinic, Scottsdale, AZ, USA.
  • Atria Academy of Science and Medicine, New York, NY, USA.

ORCID-Profile: Edita Navratilova, Caroline M Kopruszinski, Todd J Schwedt, Frank Porreca

Förderung

  • U.S. Department of Defense

Zitieren

APA

Navratilova, E., Kopruszinski, C. M., Oyarzo, J., Barber, K. R., Anderson, T., Dodick, D. W., Schwedt, T. J., & Porreca, F. (2025). Sex differences in effectiveness of CGRP receptor antagonism for treatment of acute and persistent headache-like pain in a mouse model of mild traumatic brain injury. Cephalalgia. https://doi.org/10.1177/03331024251321087

Vancouver

Navratilova E, Kopruszinski CM, Oyarzo J, Barber KR, Anderson T, Dodick DW, et al. Sex differences in effectiveness of CGRP receptor antagonism for treatment of acute and persistent headache-like pain in a mouse model of mild traumatic brain injury. Cephalalgia. 2025. doi:10.1177/03331024251321087

BibTeX
@article{Navratilova2025,
  author = {Navratilova, Edita and Kopruszinski, Caroline M and Oyarzo, Janice and Barber, Kara R and Anderson, Trent and Dodick, David W and Schwedt, Todd J and Porreca, Frank},
  title = {Sex differences in effectiveness of CGRP receptor antagonism for treatment of acute and persistent headache-like pain in a mouse model of mild traumatic brain injury},
  journal = {Cephalalgia},
  year = {2025},
  doi = {10.1177/03331024251321087}
}
Kostenlos starten →